Literature DB >> 15221447

Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.

Sylvia L Anderson1, Josef Ekstein, Mary C Donnelly, Erin M Keefe, Nicole R Toto, Lauretta A LeVoci, Berish Y Rubin.   

Abstract

Nemaline myopathy (NM) is a neuromuscular disorder that is clinically diverse and can be attributed to mutations in any of several genes. The Ashkenazi Jewish population, which represents a relatively genetically homogeneous group, has an increased frequency of several genetic disorders and has been the beneficiary of genetic screening programs that have reduced the incidence of these diseases. The identification of individuals with NM in this population has prompted a study of its cause. Our study has revealed that five NM patients from five families bear an identical 2,502-bp deletion that lies in the nebulin gene and that includes exon 55 and parts of introns 54 and 55. The absence of this exon results in the generation of a transcript that encodes 35 fewer amino acids. An analysis of the gene frequency of this mutation in a random sample of 4,090 Ashkenazi Jewish individuals has revealed a carrier frequency of one in 108. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221447     DOI: 10.1007/s00439-004-1140-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  44 in total

1.  Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.

Authors:  B B Roa; C V Savino; C S Richards
Journal:  Genet Test       Date:  1999

Review 2.  109th ENMC International Workshop: 5th workshop on nemaline myopathy, 11th-13th October 2002, Naarden, The Netherlands.

Authors:  Carina Wallgren-Pettersson; Nigel G Laing
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

3.  Molecular contacts between nebulin and actin: cross-linking of nebulin modules to the N-terminus of actin.

Authors:  C L Shih; M J Chen; K Linse; K Wang
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

4.  Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy.

Authors:  K Pelin; M Ridanpää; K Donner; S Wilton; J Krishnarajah; N Laing; B Kolmerer; S Millevoi; S Labeit; A de la Chapelle; C Wallgren-Petterson
Journal:  Eur J Hum Genet       Date:  1997 Jul-Aug       Impact factor: 4.246

5.  Fine mapping of five human skeletal muscle genes: alpha-tropomyosin, beta-tropomyosin, troponin-I slow-twitch, troponin-I fast-twitch, and troponin-C fast.

Authors:  N Tiso; L Rampoldi; A Pallavicini; R Zimbello; D Pandolfo; G Valle; G Lanfranchi; G A Danieli
Journal:  Biochem Biophys Res Commun       Date:  1997-01-13       Impact factor: 3.575

6.  Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization.

Authors:  H Ueyama; J Inazawa; T Ariyama; H Nishino; Y Ochiai; I Ohkubo; T Miwa
Journal:  Jpn J Hum Genet       Date:  1995-03

7.  Mutations in the beta-tropomyosin (TPM2) gene--a rare cause of nemaline myopathy.

Authors:  Kati Donner; Miina Ollikainen; Maaret Ridanpää; Hans-Jürgen Christen; Hans H Goebel; Marianne de Visser; Katarina Pelin; Carina Wallgren-Pettersson
Journal:  Neuromuscul Disord       Date:  2002-02       Impact factor: 4.296

8.  Lack of the C-terminal domain of nebulin in a patient with nemaline myopathy.

Authors:  J Gurgel-Giannetti; M-L Bang; U Reed; S Marie; M Zatz; S Labeit; M Vainzof
Journal:  Muscle Nerve       Date:  2002-05       Impact factor: 3.217

9.  LIGHT AND ELECTRON MICROSCOPIC STUDIES OF "MYOGRANULES" IN A CHILD WITH HYPOTONIA AND MUSCLE WEAKNESS.

Authors:  P E CONEN; E G MURPHY; W L DONOHUE
Journal:  Can Med Assoc J       Date:  1963-11-09       Impact factor: 8.262

10.  Assignment of the human a-tropomyosin gene TPM3 to 1q22-->q23 by fluorescence in situ hybridisation.

Authors:  S D Wilton; H Eyre; P A Akkari; H C Watkins; C MacRae; N G Laing; D C Callen
Journal:  Cytogenet Cell Genet       Date:  1995
View more
  29 in total

1.  Clinical utility gene card for: nemaline myopathy.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

Review 2.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

4.  Clinical utility gene card for: Nemaline myopathy - update 2015.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

5.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.

Authors:  Stuart A Scott; Lisa Edelmann; Liu Liu; Minjie Luo; Robert J Desnick; Ruth Kornreich
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

Review 6.  Nebulin, a major player in muscle health and disease.

Authors:  Siegfried Labeit; Coen A C Ottenheijm; Henk Granzier
Journal:  FASEB J       Date:  2010-11-29       Impact factor: 5.191

7.  The exon 55 deletion in the nebulin gene--one single founder mutation with world-wide occurrence.

Authors:  Vilma-Lotta Lehtokari; Rebecca S Greenleaf; Elizabeth T DeChene; Mutsumi Kellinsalmi; Katarina Pelin; Nigel G Laing; Alan H Beggs; Carina Wallgren-Pettersson
Journal:  Neuromuscul Disord       Date:  2009-02-15       Impact factor: 4.296

8.  Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy.

Authors:  Coen A C Ottenheijm; Danielle Buck; Josine M de Winter; Claudia Ferrara; Nicoletta Piroddi; Chiara Tesi; Jeffrey R Jasper; Fady I Malik; Hui Meng; Ger J M Stienen; Alan H Beggs; Siegfried Labeit; Corrado Poggesi; Michael W Lawlor; Henk Granzier
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

9.  Nebulin (NEB) mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing.

Authors:  Mariacristina Scoto; Thomas Cullup; Sebahattin Cirak; Shu Yau; Adnan Y Manzur; Lucy Feng; Thomas S Jacques; Glenn Anderson; Stephen Abbs; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

10.  Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2).

Authors:  Coen A C Ottenheijm; Pleuni Hooijman; Elizabeth T DeChene; Ger J Stienen; Alan H Beggs; Henk Granzier
Journal:  J Struct Biol       Date:  2009-11-26       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.